Researchers Identify Novel Class of Drugs for Prostate Cancers That Disrupts Growth Signaling
Tuesday, May 28, 2013 - 16:30
in Health & Medicine
A new study on prostate cancer describes a novel class of drugs developed by UT Southwestern Medical Center researchers that interrupts critical signaling needed for prostate cancer cells to grow.